In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.
about
In vitro activity of BAY 12-8039, a new fluoroquinoloneActivities of gatifloxacin compared to those of seven other agents against anaerobic organisms.Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitisActivity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections.Efficacy of gatifloxacin in experimental Escherichia coli meningitis.In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteriaMechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus.Clinical pharmacology of gatifloxacin, a new fluoroquinolone.In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.The new fluoroquinolones: A critical reviewContribution of the R8 substituent to the in vitro antibacterial potency of besifloxacin and comparator ophthalmic fluoroquinolones.Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium.Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms.Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus.Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.Determination of gatifloxacin in human plasma by liquid chromatography/electrospray tandem mass spectrometry.
P2860
Q28379381-1CA10E98-7DA8-4197-B06F-5C7E26F35951Q33697562-50210F55-05AE-4E39-B711-18FD9F9A1028Q33699541-1B93451E-584F-4E14-A401-60BCB3953AC6Q33961044-CADF0FE6-FBD5-4B17-B609-07343C498A47Q33976981-4B7905D2-84AE-4D9B-A1E5-2B6376922993Q33977276-B6E2B35A-F439-418E-B480-BE24DC1FE0E9Q33978131-397B04E7-D90D-4BE5-B8A5-9FDBB25C47F1Q33983092-2AD69CA8-4F99-4516-8359-411B96F00326Q34030783-1C60EDBA-09DB-4702-A7A7-9863C66A1BCBQ35136707-692C47E9-6E50-4F26-8604-0D94C6201F02Q35139557-95E98062-B831-4AC9-A890-F83D3BBFC392Q35649595-E12946CB-7A43-4AAB-87A3-F7E955B89288Q36825816-EB8CD8A5-EB5D-493A-BED6-DF14DDCB6B1DQ39470007-9CDA5C4D-31E4-46EC-8073-4F7D872DD2FDQ39472095-0D14EADE-3CD5-4D03-BD03-2A22B597C280Q39558211-ECDBE15E-8E2B-4789-8834-6A0BE8659033Q39559188-2AB88D05-A86F-4728-8AF4-2B3FCAB24567Q39559460-F84859CF-5CD8-4638-AC99-80140D63CF0BQ39780917-E78D7991-3745-4577-993A-1B1D0A6079C4Q43635716-5EEABCEF-1C74-4499-A2EE-747CD98829E0
P2860
In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.
@en
type
label
In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.
@en
prefLabel
In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.
@en
P2860
P356
P1476
In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.
@en
P2093
E Wakabayashi
S Mitsuhashi
P2860
P304
P356
10.1128/AAC.38.3.594
P407
P577
1994-03-01T00:00:00Z